Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocugen (OCGN) EBITDA (2016 - 2025)

Historic EBITDA for Ocugen (OCGN) over the last 12 years, with Q3 2025 value amounting to -$20.0 million.

  • Ocugen's EBITDA fell 5418.11% to -$20.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$64.0 million, marking a year-over-year decrease of 2509.78%. This contributed to the annual value of -$54.0 million for FY2024, which is 1435.86% up from last year.
  • Latest data reveals that Ocugen reported EBITDA of -$20.0 million as of Q3 2025, which was down 5418.11% from -$14.8 million recorded in Q2 2025.
  • Ocugen's 5-year EBITDA high stood at -$7.1 million for Q1 2021, and its period low was -$26.0 million during Q2 2021.
  • In the last 5 years, Ocugen's EBITDA had a median value of -$15.3 million in 2024 and averaged -$16.4 million.
  • In the last 5 years, Ocugen's EBITDA crashed by 61809.63% in 2021 and then surged by 5099.12% in 2023.
  • Over the past 5 years, Ocugen's EBITDA (Quarter) stood at -$14.6 million in 2021, then crashed by 53.61% to -$22.4 million in 2022, then surged by 50.99% to -$11.0 million in 2023, then decreased by 26.22% to -$13.9 million in 2024, then crashed by 44.39% to -$20.0 million in 2025.
  • Its last three reported values are -$20.0 million in Q3 2025, -$14.8 million for Q2 2025, and -$15.4 million during Q1 2025.